Europe’s Evolving Role in Global Clinical Trials

As global clinical development strategies evolve, Europe is emerging as a critical hub for scientific innovation, operational agility, and patient recruitment — reshaping its role in the future of clinical trials. In this episode, Scott Davis, Vice President of Clinical Services at Novotech, joins Andrew Warmington from Citeline to explore how sponsors are rethinking Europe’s place in global development programs amid shifting geopolitical, regulatory, and operational dynamics. They discuss: · Why Europe continues to lead through scientific expertise and clinical innovation · How sponsors are optimizing trial design, startup, and recruitment strategies across the region · The growing importance of flexible CRO–sponsor partnerships in global development · How Europe complements the US and APAC in modern clinical trial strategies · What regulatory evolution and operational change could mean for Europe’s future competitiveness Tune in to hear how Europe is adapting to a rapidly changing clinical landscape and why the region is poised to play an even greater role in the future of global clinical trials.

You can listen to Europe’s Evolving Role in Global Clinical Trials online on Radio and Podcast. Open the player on this page to stream the available audio.

Europe’s Evolving Role in Global Clinical Trials is an episode from Pharma Intelligence Podcasts.

This episode is 10:25 long.

This episode was published on May 18, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Pharma Intelligence Podcasts when more episodes are available from the podcast feed.